TriSalus Life Sciences Inc.
TLSI | NASDAQ
$4.98
-$0.12 (-2.35%)
At close: Sep 21, 2026, 4:00 PM ET
$5.07
+$0.09 (+1.81%)
After-hours:
Sep 21, 2026, 4:13 PM ET
Market Data
Market Cap $306.64M
Enterprise Value $294.78M
Beta 0.44
Average Volume 390.29K
Shares Outstanding (Diluted) 58.3M
Shares Change YoY 77.2%
Institutional Ownership 40.46%
Exchange NASDAQ
ISIN US89680M1018
Price Performance
Price Change 1M -3.7%
Price Change 3M 23.6%
Price Change 6M 24.2%
Price Change YTD -18.4%
Price Change 1Y 2.0%
Price Change 3Y -9.4%
Price Change 5Y -49.9%
1M CAGR (ann.) -11.2%
1Y CAGR (ann.) 1.2%
5Y CAGR (ann.) -12.8%
All-Time CAGR -12.5%
Valuation
PE Ratio -3.83
Forward PE 83.33
PEG Ratio 0.07
Forward PEG 0.20
PS Ratio 6.80
Forward PS 4.10
PB Ratio 46.82
P/FCF Ratio -10.25
P/Adj. FCF Ratio -7.12
P/OCF Ratio -9.96
EV/Sales 6.54
EV/EBIT -13.18
EV/EBITDA -13.61
EV/FCF -9.86
Earnings Yield -26.1%
FCF Yield -9.8%
Adj. FCF Yield -14.1%
Financial Health
Net Cash $11.86M
Total Debt $34.43M
Cash & Short-Term Investments $46.29M
Total Assets $62.45M
Current Ratio 5.35
Quick Ratio 4.97
Debt / Equity Ratio 5.26
Debt / EBITDA -1.59
Debt / FCF -1.15
OCF / Debt -0.85
Interest Coverage -5.23
Altman Z-Score -3.82
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 85.8%
Operating Profit Margin -67.7%
EBITDA Margin -48.1%
Net Profit Margin -62.6%
FCF Margin -66.3%
Adj. FCF Margin -95.6%
SBC / Revenue 29.2%
SBC Impact (per share) -44.1%
Returns
Return on Assets -45.2%
Return on Equity 273.7%
Return on Invested Capital -59.2%
Return on Capital Employed -59.5%
Return on Tangible Assets -45.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 45.1%
Revenue CAGR 5Y 37.3%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 28.8%
EPS CAGR 5Y -14.4%
EPS CAGR 10Y N/A
FCF CAGR 3Y 33.8%
FCF CAGR 5Y 0.9%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 3
EPS Growth Next 3Y 45.9%
Revenue Growth Next 3Y 46.4%
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$0.12
EPS Growth Est (next Q) -87.5%
Revenue Est (next Q) $14.31M
Revenue Growth Est (next Q) 23.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $9.50
Price Target Upside 90.8%
Cash Flow
Operating Cash Flow $-29.28M
Free Cash Flow $-29.9M
Adj. Free Cash Flow $-43.08M
FCF Per Share -$0.51
OCF Per Share -$0.50
OCF/S Ratio -65.0%
Income Statement
Revenue $45.08M
Gross Profit $38.67M
Operating Income $-30.51M
EBITDA $-21.67M
Net Income $-28.21M
EPS (Diluted) -$1.30
Revenue / Employee $441.93K
Profit / Employee $-276.59K
Employees 102
Add to Watchlist
Select watchlists to add or remove TLSI